| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |